Transcutaneous Electrical Nerve Stimulation Demonstrates Long-term Reduction of Ocular Pain
Use of a transcutaneous electrical nerve stimulation (TENS) can significantly reduce subjective pain intensity, according to a poster presented at the American Society of Cataract and Refractive Surgery (ASCRS) virtual annual meeting.
Ten patients using a TENS device for at least 3 months reported using the device 14 times per week initially before reducing frequency to an average of 6 times per week. Subjective pain reduction after using the device was reported in 90% of patients. After treatment, pain intensity decreased by approximately 27% (P = 0.013) compared to prior to treatment.
No adverse events were reported.
The authors concluded that TENS can be “integrated into long-term management of ocular pain.”
Reference
Staropoli PC, et al. Transcutaneous electrical nerve stimulation for the long term treatment of ocular pain. Poster presented at: American Society of Cataract and Refractive Surgery (ASCRS) Virtual Annual Meeting. May 16-17, 2020.
Related Content
